CIPO Patents = 2

EPO Patents = 2

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Zhaoyin Wang (4 out of 50 patents)

Lianhai Li (3 out of 9 patents)

Zhigang Wang (2 out of 2 patents)

4. Wei W Yuan (0 patent)

4 patents: Sort by Forward Citations

1. 9458162 - Cyclic molecules as bruton's tyrosine kinase inhibitors (2016-10-04),

2. 9345905 - Heterocyclic amides compounds which are HDAC6 inhibitors and used as anti-tumoral agents (2016-05-24),

3. 9226923 - Spirocyclic molecules as protein kinase inhibitors (2016-01-05),

4. 8946445 - Heterocyclic molecules as apoptosis inducers (2015-02-03),

Nanjing Allgen Pharma Co. Ltd. is a leading pharmaceutical company specializing in research, development, and production of innovative medicines. With a strong focus on biotechnology, Allgen Pharma is committed to improving patient health through cutting-edge therapies. Headquartered in Nanjing, China, the company is dedicated to providing high-quality, affordable healthcare solutions to patients around the world.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

4 Patents

#90 in Nanjing

#5,594 in China

Nanjing, China

Nanjing Allgen Pharma Co. Ltd.

Forward Citations = 4

3 inventors:

Zhaoyin Wang (4 out of 50 patents)

Lianhai Li (3 out of 9 patents)

Zhigang Wang (2 out of 2 patents)

4. Wei W Yuan (0 patent)

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

2 patents (EPO):

Please report any incorrect information to support@idiyas.com